informed consent
Beyond Informed Consent: New Ethics Protocols for Biobanking
June 16 by Amber ScorahIn the context of research involving biobanks, informed consent fails in the two most salient dimensions: in its usual format, informed consent both inhibits important research and yet also fails to...
Human Tissue Biobanks: Is it Possible for the Subject to Give Meaningful Informed Consent?
June 06 by Andrea CharlesKieran O’Doherty, PhD, Assistant Professor, University of Guelph, talks to Andrea Charles from Pharma IQ, about ethical, legal, and social issues surrounding biobanks, and how e...
Biobanking: Truth and Transparency
October 22 by Pharma IQPublic awareness of biobanking is growing and lack of transparency can lead to closure of a biobanking project. David Kaufman, Director of Research and Statistics Genetics and Public Policy Cen...
A Retrospective on the Evolution of Pharmacovigilance
April 26 by Amber ScorahTo understand where we are going, we need to understand where we’ve been. In this interview with Pharma IQ, Paul Beninger, Vice President, Global Patient Safety and Risk Management at Genzyme...
Biobanking: Current Failures and New Models of Consent
April 26 by Kieran O’DohertyKieran O’Doherty, Assistant Professor at the University of Guelph, joins Pharma IQ to discuss current failures and new models of consent in biobanking. Pharma IQ: Thanks for joining us. Now...